Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114946) titled 'An intelligent paper-based microfluidic platform based on "controllable grafting and azide-coated layer" nanozyme@molecular imprinting probes is used for BTMs detection and OP screening' on Dec. 19, 2025.
Study Type: Observational study
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Chongqing University Three Gorges Hospital
Condition:
osteoporosis
Intervention:
Healthy group:No intervention
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-01-01
Target Sample Size: Healthy group:50;Osteoporosis group:150;
Countries of Recruitment:
Chian
To know more, visit h...